Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Pilot Study of the Safety, Tolerability and Pharmacokinetics of Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy

NCT00056238 is registered in ClinicalTrials.gov with Bellus Health Inc. - a GSK company as lead sponsor.

NCT NCT00056238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00056238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Pilot Study of the Safety, Tolerability and Pharmacokinetics of Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy
Lead sponsor
Bellus Health Inc. - a GSK company
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2003
Completion date
Not reported
Enrollment
30
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

neurologic diseases, general, stroke